Practice Management

A Resident's Perspective: SGLT2 Inhibitors for Primary Prevention

December 08, 2020

A resident from Penn State Hershey Medical Center offers his perspective on the potential of the SGLT2 inhibitor class to transform the treatment of diabetes and cardiovascular disease among patients with diabetes.